The vaccine has been developed using the same viral- vector platform as the Oxford/AstraZeneca COVID-19 vaccine and involves manufacturing processes that were originally used for the Covid vaccine, Prof Brian Angus, chief investigator of the trial at…
Oxford University launches world’s first Phase II Nipah virus vaccine trial: Why is this significant?
